{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T00:46:51Z","timestamp":1699145211009},"reference-count":23,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"vor","delay-in-days":17946,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Pharmacology and Chemotherapy"],"published-print":{"date-parts":[[1963,6]]},"abstract":"<jats:p>The effects of mepyramine, promethazine, chlorpromazine and lysergic acid diethylamide have been compared on the capillary permeability changes of the skin, produced by histamine, by 5\u2010hydroxytryptamine and by passive cutaneous anaphylaxis in mice. Promethazine, mepyramine and chlorpromazine can inhibit, in decreasing order of activity, the effect of histamine, whilst lysergic acid diethylamide is inactive. Lysergic acid diethylamide and chlorpromazine are equally potent inhibitors of the action of 5\u2010hydroxytryptamine on the peripheral vascular bed, whilst mepyramine is inactive. Promethazine has intermediate activity. Passive cutaneous anaphylaxis is strongly inhibited by chlorpromazine and by promethazine. Mepyramine and lysergic acid diethylamide, each injected alone, affect only weakly the anaphylactic reaction. However, passive cutaneous anaphylaxis is almost completely abolished by the simultaneous injection of the two last antagonists. It is suggested that the anaphylactic reaction in mice is the result of simultaneous release of both mediators, histamine and 5\u2010hydroxytryptamine, each of them strengthening the effect of the other.<\/jats:p>","DOI":"10.1111\/j.1476-5381.1963.tb01477.x","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T16:22:44Z","timestamp":1342801364000},"page":"389-398","source":"Crossref","is-referenced-by-count":11,"title":["ON THE NATURE OF THE CHEMICAL MEDIATORS INVOLVED IN ANAPHYLACTIC REACTIONS IN MICE"],"prefix":"10.1111","volume":"20","author":[{"given":"B. N.","family":"HALPERN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"NEVEU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"SPECTOR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1937.sp003476"},{"issue":"2","key":"e_1_2_1_3_1","first-page":"1","article-title":"Contribution \u00e0 la pathog\u00e9nie de l'anaphylaxie cutan\u00e9e chez le rat","volume":"20","author":"Craps L.","year":"1962","journal-title":"Int. Arch. Allergy"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-92-22579"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4049\/jimmunol.88.5.595","article-title":"Studies on the effect of complement on anaphylaxis in the mouse","volume":"88","author":"Frick O. L.","year":"1962","journal-title":"J. Immunol"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.115.2.367"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-8707(47)90050-6"},{"key":"e_1_2_1_8_1","first-page":"247","volume-title":"Lex Antihistaminiques de Synth\u00e8se D\u00e9riv\u00e9s de la Phenothiazine. Report presented at the IInd Int. Congr. Therapeutics","author":"Halpern B. N.","year":"1949"},{"key":"e_1_2_1_9_1","first-page":"385","volume-title":"Proc. IIIrd Int. Congr. Allergology","author":"Halpern B. N.","year":"1958"},{"key":"e_1_2_1_10_1","first-page":"361","article-title":"Recherches exp\u00e9rimentales sur une nouvelles s\u00e9rie chimique de corps dou\u00e9s de propri\u00e9t\u00e9s antihistaminiques puissantes: les d\u00e9riv\u00e9s de la thiodiphenylamine","volume":"140","author":"Halpern B. N.","year":"1946","journal-title":"C.R. Soc. Biol. (Paris"},{"key":"e_1_2_1_11_1","first-page":"322","article-title":"A new synthetic antihistaminic substance derived from phenothiazine (Phenergan)","volume":"59","author":"Halpern B. N.","year":"1948","journal-title":"Canad. med. Ass. J."},{"key":"e_1_2_1_12_1","first-page":"56","article-title":"Recherches sur les substances exog\u00e8nes et endog\u00e8nes agissant sur la perm\u00e9abilit\u00e9 capillaire et leurs antagonistes","volume":"119","author":"Halpern B. N.","year":"1959","journal-title":"Arch. Int. Pharmacodyn"},{"key":"e_1_2_1_13_1","first-page":"314","article-title":"L'anaphylaxie exp\u00e9rimentale du rat albinos","volume":"149","author":"Halpern B. N.","year":"1955","journal-title":"C.R. Soc. Biol. (Paris"},{"key":"e_1_2_1_14_1","first-page":"31","article-title":"The mechanism of anaphylaxis. Specificity of antigen\u2010induced mast cell damage in anaphylaxis in the guinea\u2010pig","volume":"2","author":"Humphrey J. H.","year":"1959","journal-title":"Immunology"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000256116"},{"key":"e_1_2_1_16_1","volume-title":"Experimental Immunochemistry","author":"Kabat E. A.","year":"1961"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj0300227"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-8707(52)90055-5"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-95-23355"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4049\/jimmunol.81.4.355","article-title":"Passive cutaneous anaphylaxis in the mouse","volume":"81","author":"Ovary Z.","year":"1958","journal-title":"J. Immunol"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1957.sp005805"},{"key":"e_1_2_1_22_1","first-page":"363","article-title":"Antihistaminiques de Synth\u00e8se et choc anaphylactique chez le lapin","volume":"78","author":"Reuse J. J.","year":"1949","journal-title":"Arch. Int. Pharmacodyn"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.103.4.399"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1957.sp005795"}],"container-title":["British Journal of Pharmacology and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.1963.tb01477.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.1963.tb01477.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T14:03:35Z","timestamp":1699106615000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.1963.tb01477.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1963,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1963,6]]}},"alternative-id":["10.1111\/j.1476-5381.1963.tb01477.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.1963.tb01477.x","archive":["Portico"],"relation":{},"ISSN":["0366-0826"],"issn-type":[{"value":"0366-0826","type":"print"}],"subject":[],"published":{"date-parts":[[1963,6]]}}}